{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:53:08Z","timestamp":1787064788601,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR078949"],"award-info":[{"award-number":["AR078949"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR073752"],"award-info":[{"award-number":["AR073752"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG15786"],"award-info":[{"award-number":["AG15786"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-024-03425-3","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T23:41:43Z","timestamp":1730850103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Engineered self-regulating macrophages for targeted anti-inflammatory drug delivery"],"prefix":"10.1186","volume":"26","author":[{"given":"Molly","family":"Klimak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke E.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Harasymowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine T.N.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Guilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"15","key":"3425_CR1","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3390\/jcm10153289","volume":"10","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wu Q. Prevalence trend and disparities in rheumatoid arthritis among US adults, 2005\u20132018. J Clin Med. 2021;10(15):3289.","journal-title":"J Clin Med"},{"key":"3425_CR2","doi-asserted-by":"crossref","unstructured":"Kuo D, Ding J, Cohn IS, Zhang F, Wei K, Rao DA, Rozo C, Sokhi UK, Shanaj S, Oliver DJ, Echeverria AP, DiCarlo EF, Brenner MB, Bykerk VP, Goodman SM, Raychaudhuri S, R\u00e4tsch G, Ivashkiv LB, Donlin LT. HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness. Sci Transl Med. 2019;11(491):eaau8587.","DOI":"10.1126\/scitranslmed.aau8587"},{"issue":"5","key":"3425_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/ar2292","volume":"9","author":"M Otero","year":"2007","unstructured":"Otero M, Goldring MB. Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Res Ther. 2007;9(5):220.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3425_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3831\/KPI.2019.22.029","volume":"22","author":"D Kesharwani","year":"2019","unstructured":"Kesharwani D, Paliwal R, Satapathy T, Das Paul S. Rheumatiod Arthritis: an updated overview of latest therapy and drug delivery. J Pharmacopunct. 2019;22(4):210\u201324.","journal-title":"J Pharmacopunct"},{"issue":"5","key":"3425_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/ard.2009.121657","volume":"69","author":"G Schett","year":"2010","unstructured":"Schett G, Firestein GS. Mr outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis. 2010;69(5):787\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3425_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"J Falconer","year":"2018","unstructured":"Falconer J, Murphy AN, Young SP, Clark AR, Tiziani S, Guma M, Buckley CD. Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2018;70(7):984\u201399.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3425_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","volume":"9","author":"EH Choy","year":"2013","unstructured":"Choy EH, Kavanaugh AF, Jones SA. The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol. 2013;9(3):154\u201363.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"3425_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3425_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cyto.2014.10.006","volume":"74","author":"DM Roeleveld","year":"2015","unstructured":"Roeleveld DM, Koenders MI. The role of the Th17 cytokines IL-17 and IL-22 in rheumatoid arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine. 2015;74(1):101\u20137.","journal-title":"Cytokine"},{"key":"3425_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.intimp.2018.12.040","volume":"67","author":"D Chen","year":"2019","unstructured":"Chen D, Liu H, Wang Y, Chen S, Liu J, Li W, Dou H, Hou W, Meng M. Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells. Int Immunopharmacol. 2019;67:427\u201340.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3425_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cyto.2014.06.019","volume":"70","author":"RE Miller","year":"2014","unstructured":"Miller RE, Miller RJ, Malfait AM. Osteoarthritis joint pain: the cytokine connection. Cytokine. 2014;70(2):185\u201393.","journal-title":"Cytokine"},{"key":"3425_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.imlet.2016.05.001","volume":"178","author":"U Srenathan","year":"2016","unstructured":"Srenathan U, Steel K, Taams LS. IL-17\u2009+\u2009CD8\u2009+\u2009T cells: differentiation, phenotype and role in inflammatory disease. Immunol Lett. 2016;178:20\u20136.","journal-title":"Immunol Lett"},{"issue":"6","key":"3425_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/ar2333","volume":"9","author":"RW Kinne","year":"2007","unstructured":"Kinne RW, Stuhlmuller B, Burmester GR. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther. 2007;9(6):224.","journal-title":"Arthritis Res Ther"},{"issue":"3 Suppl","key":"3425_CR14","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/01.rhu.0000130687.75646.44","volume":"10","author":"G Weissmann","year":"2004","unstructured":"Weissmann G. Pathogenesis of rheumatoid arthritis. J Clin Rheumatol. 2004;10(3 Suppl):S26\u201331.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"3425_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/cei.13098","volume":"193","author":"S Alivernini","year":"2018","unstructured":"Alivernini S, Tolusso B, Ferraccioli G, Gremese E, Kurowska-Stolarska M, McInnes IB. Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells. Clin Exp Immunol. 2018;193(1):13\u201323.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3425_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB. Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017;46(2):183\u201396.","journal-title":"Immunity"},{"issue":"7771","key":"3425_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","volume":"572","author":"S Culemann","year":"2019","unstructured":"Culemann S, Gruneboom A, Nicolas-Avila JA, Weidner D, Lammle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, Ferrazzi F, Kretzschmar E, Schicht M, Fischer K, Gelse K, Faas M, Pfeifle R, Ackermann JA, Pachowsky M, Renner N, Simon D, Haseloff RF, Ekici AB, Bauerle T, Blasig IE, Vera J, Voehringer D, Kleyer A, Paulsen F, Schett G, Hidalgo A, Kronke G. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572(7771):670\u20135.","journal-title":"Nature"},{"issue":"4","key":"3425_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Med (Baltim). 2007;86(4):242\u201351.","journal-title":"Med (Baltim)"},{"issue":"18","key":"3425_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6391","volume":"6","author":"PL Graney","year":"2020","unstructured":"Graney PL, Ben-Shaul S, Landau S, Bajpai A, Singh B, Eager J, Cohen A, Levenberg S, Spiller KL. Macrophages of diverse phenotypes drive vascularization of engineered tissues. Sci Adv. 2020;6(18): eaay6391.","journal-title":"Sci Adv"},{"issue":"44","key":"3425_CR20","doi-asserted-by":"publisher","first-page":"12514","DOI":"10.1073\/pnas.1613884113","volume":"113","author":"VT Chu","year":"2016","unstructured":"Chu VT, Graf R, Wirtz T, Weber T, Favret J, Li X, Petsch K, Tran NT, Sieweke MH, Berek C, Kuhn R, Rajewsky K. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL\/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113(44):12514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3425_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clim.2012.12.011","volume":"146","author":"A Haseeb","year":"2013","unstructured":"Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146(3):185\u201396.","journal-title":"Clin Immunol"},{"issue":"7","key":"3425_CR22","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.joca.2017.02.791","volume":"25","author":"CY Yang","year":"2017","unstructured":"Yang CY, Chanalaris A, Troeberg L. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the \u2018usual suspects.\u2019 Osteoarthritis Cartilage. 2017;25(7):1000\u20139.","journal-title":"Osteoarthritis Cartilage"},{"key":"3425_CR23","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","volume":"10","author":"M Gschwandtner","year":"2019","unstructured":"Gschwandtner M, Derler R, Midwood KS. More than just attractive: how CCL2 influences myeloid cell Behavior Beyond Chemotaxis. Front Immunol. 2019;10:2759.","journal-title":"Front Immunol."},{"key":"3425_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jconrel.2016.01.026","volume":"240","author":"MM Alvarez","year":"2016","unstructured":"Alvarez MM, Liu JC, Trujillo-de Santiago G, Cha BH, Vishwakarma A, Ghaemmaghami AM, Khademhosseini A. Delivery strategies to control inflammatory response: modulating M1-M2 polarization in tissue engineering applications. J Control Release. 2016;240:349\u201363.","journal-title":"J Control Release"},{"issue":"6","key":"3425_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/1735-5362.272534","volume":"14","author":"J Emami","year":"2019","unstructured":"Emami J, Ansarypour Z. Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis. Res Pharm Sci. 2019;14(6):471\u201387.","journal-title":"Res Pharm Sci"},{"issue":"7","key":"3425_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","volume":"17","author":"J Ramirez","year":"2018","unstructured":"Ramirez J, Canete JD. Anakinra for the treatment of rheumatoid arthritis: a safety evaluation. Expert Opin Drug Saf. 2018;17(7):727\u201332.","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"3425_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2016.13512","volume":"316","author":"JE Gottenberg","year":"2016","unstructured":"Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Liote F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P. Non-TNF-Targeted biologic vs a second Anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first Anti-TNF drug: a randomized clinical trial. JAMA. 2016;316(11):1172\u201380.","journal-title":"JAMA"},{"issue":"3","key":"3425_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/art.24096","volume":"61","author":"X Chevalier","year":"2009","unstructured":"Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2009;61(3):344\u201352.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3425_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/hum.2017.181","volume":"29","author":"CH Evans","year":"2018","unstructured":"Evans CH, Ghivizzani SC, Robbins PD. Gene delivery to joints by Intra-articular Injection. Hum Gene Ther. 2018;29(1):2\u201314.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"3425_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/hum.2008.075","volume":"20","author":"P Wehling","year":"2009","unstructured":"Wehling P, Reinecke J, Baltzer AW, Granrath M, Schulitz KP, Schultz C, Krauspe R, Whiteside TW, Elder E, Ghivizzani SC, Robbins PD, Evans CH. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther. 2009;20(2):97\u2013101.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"3425_CR31","doi-asserted-by":"publisher","first-page":"R134","DOI":"10.1186\/ar4591","volume":"16","author":"BD Furman","year":"2014","unstructured":"Furman BD, Mangiapani DS, Zeitler E, Bailey KN, Horne PH, Huebner JL, Kraus VB, Guilak F, Olson SA. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther. 2014;16(3):R134.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3425_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00296-009-0872-0","volume":"29","author":"A Fioravanti","year":"2009","unstructured":"Fioravanti A, Fabbroni M, Cerase A, Galeazzi M. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int. 2009;29(8):961\u20135.","journal-title":"Rheumatol Int"},{"issue":"4","key":"3425_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/ard.2006.053272","volume":"65","author":"M Grunke","year":"2006","unstructured":"Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis. 2006;65(4):555\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"3425_CR34","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.3390\/ijms241512307","volume":"24","author":"N Kikyo","year":"2023","unstructured":"Kikyo N. Circadian regulation of macrophages and osteoclasts in rheumatoid arthritis. Int J Mol Sci. 2023;24(15):12307.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3425_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2018-213454","volume":"78","author":"DT Ewart","year":"2019","unstructured":"Ewart DT, Peterson EJ, Steer CJ. Gene editing for inflammatory disorders. Ann Rheum Dis. 2019;78(1):6\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3425_CR36","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jor.24304","volume":"37","author":"F Guilak","year":"2019","unstructured":"Guilak F, Pferdehirt L, Ross AK, Choi Y-R, Collins K, Nims RJ, Katz DB, Klimak M, Tabbaa S, Pham CTN. Designer stem cells: Genome Engineering and the Next Generation of Cell-based therapies. J Orthop Res. 2019;37(6):1287\u201393.","journal-title":"J Orthop Res"},{"issue":"3","key":"3425_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08923973.2018.1437625","volume":"40","author":"F Safari","year":"2018","unstructured":"Safari F, Farajnia S, Arya M, Zarredar H, Nasrolahi A. CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018;40(3):201\u201311.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"3425_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/art.39982","volume":"69","author":"JM Brunger","year":"2017","unstructured":"Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. CRISPR\/Cas9 editing of Murine Induced Pluripotent Stem cells for Engineering inflammation-resistant tissues. Arthritis Rheumatol. 2017;69(5):1111\u201321.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"3425_CR39","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","volume":"8","author":"JM Brunger","year":"2017","unstructured":"Brunger JM, Zutshi A, Willard VP, Gersbach CA, Guilak F. Genome Engineering of Stem cells for autonomously regulated, closed-Loop delivery of biologic drugs. Stem Cell Rep. 2017;8(5):1202\u201313.","journal-title":"Stem Cell Rep"},{"issue":"18","key":"3425_CR40","doi-asserted-by":"publisher","first-page":"eaaz6579","DOI":"10.1126\/sciadv.aaz6579","volume":"6","author":"CWt Shields","year":"2020","unstructured":"Shields CWt, Evans MA, Wang LL, Baugh N, Iyer S, Wu D, Zhao Z, Pusuluri A, Ukidve A, Pan DC, Mitragotri S. Cellular backpacks for macrophage immunotherapy. Sci Adv. 2020;6(18):eaaz6579.","journal-title":"Sci Adv"},{"key":"3425_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00022","volume":"10","author":"JG Visser","year":"2019","unstructured":"Visser JG, Van Staden ADP, Smith C. Harnessing macrophages for controlled-release drug delivery: lessons from microbes. Front Pharmacol. 2019;10: 22.","journal-title":"Front Pharmacol"},{"key":"3425_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/ten.tea.2019.0027","volume":"25","author":"LR Pferdehirt","year":"2019","unstructured":"Pferdehirt LR, Brunger AK, Guilak F. A synthetic gene circuit for self-regulating delivery of biologic drugs in engineered tissues. Tissue Eng Part A. 2019;25:809\u201320.","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"3425_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/br.2016.708","volume":"5","author":"J Zhao","year":"2016","unstructured":"Zhao J, Ouyang Q, Hu Z, Huang Q, Wu J, Wang R, Yang M. A protocol for the culture and isolation of murine synovial fibroblasts. Biomed Rep. 2016;5(2):171\u20135.","journal-title":"Biomed Rep"},{"key":"3425_CR44","doi-asserted-by":"publisher","unstructured":"Armaka M, Gkretsi V, Kontoyiannis D, Kollias G. A standardized protocol for the isolation and culture of normal and arthritogenic murine synovial fibroblasts. 2009. PROTOCOL (Version 1) available at Protocol Exchange https:\/\/doi.org\/10.1038\/nprot.2009.102.","DOI":"10.1038\/nprot.2009.102"},{"issue":"47","key":"3425_CR45","doi-asserted-by":"publisher","first-page":"19172","DOI":"10.1073\/pnas.1210422109","volume":"109","author":"BO Diekman","year":"2012","unstructured":"Diekman BO, Christoforou N, Willard VP, Sun H, Sanchez-Adams J, Leong KW, Guilak F. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109(47):19172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3425_CR46","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/s41598-018-21184-5","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang H, Huang L, Welch I, Norley C, Holdsworth DW, Beier F, Cai D. Early changes of articular cartilage and subchondral bone in the DMM Mouse Model of Osteoarthritis. Sci Rep. 2018;8(1):2855.","journal-title":"Sci Rep"},{"key":"3425_CR47","first-page":"15 22 1","volume":"15","author":"PA Monach","year":"2008","unstructured":"Monach PA, Mathis D, Benoist C. The K\/BxN arthritis model. Curr Protoc Immunol. 2008;15:15 22 1\u201315.22.12.","journal-title":"Curr Protoc Immunol"},{"key":"3425_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fimmu.2016.00213","volume":"7","author":"AD Christensen","year":"2016","unstructured":"Christensen AD, Haase C, Cook AD, Hamilton JA. K\/BxN serum-transfer arthritis as a model for human inflammatory arthritis. Front Immunol. 2016;7:213.","journal-title":"Front Immunol"},{"issue":"36","key":"3425_CR49","doi-asserted-by":"publisher","first-page":"eabj1414","DOI":"10.1126\/sciadv.abj1414","volume":"7","author":"YR Choi","year":"2021","unstructured":"Choi YR, Collins KH, Springer LE, Pferdehirt L, Ross AK, Wu CL, Moutos FT, Harasymowicz NS, Brunger JM, Pham CTN, Guilak F. A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery. Sci Adv. 2021;7(36):eabj1414.","journal-title":"Sci Adv"},{"key":"3425_CR50","unstructured":"Sobi, KINERET (anakinra) prescribing information. 2020. https:\/\/www.kineretrx.com\/pdf\/Full-Prescribing-Information-English.pdf."},{"issue":"2","key":"3425_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/gels9020169","volume":"9","author":"KH Collins","year":"2023","unstructured":"Collins KH, Pferdehirt L, Saleh LS, Savadipour A, Springer LE, Lenz KL, Thompson DM Jr, Oswald SJ, Pham CTN, Guilak F. Hydrogel Encapsulation of Genome-Engineered stem cells for long-term self-regulating Anti-cytokine Therapy. Gels. 2023;9(2):169.","journal-title":"Gels"},{"issue":"11","key":"3425_CR52","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/art.38780","volume":"66","author":"VP Willard","year":"2014","unstructured":"Willard VP, Diekman BO, Sanchez-Adams J, Christoforou N, Leong KW, Guilak F. Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. Arthritis Rheumatol. 2014;66(11):3062\u201372.","journal-title":"Arthritis Rheumatol"},{"key":"3425_CR53","first-page":"485","volume":"3","author":"K Thaler","year":"2009","unstructured":"Thaler K, Chandiramani DV, Hansen RA, Gartlehner G. Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project. Biologics. 2009;3:485\u201398.","journal-title":"Biologics"},{"issue":"1","key":"3425_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00281-003-0131-5","volume":"25","author":"D Kyburz","year":"2003","unstructured":"Kyburz D, Corr M. The KRN mouse model of inflammatory arthritis. Springer Semin Immunopathol. 2003;25(1):79\u201390.","journal-title":"Springer Semin Immunopathol"},{"key":"3425_CR55","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.2147\/IJN.S298159","volume":"16","author":"T Liang","year":"2021","unstructured":"Liang T, Zhang R, Liu X, Ding Q, Wu S, Li C, Lin Y, Ye Y, Zhong Z, Zhou M. Recent advances in macrophage-mediated drug Delivery systems. Int J Nanomed. 2021;16:2703\u201314.","journal-title":"Int J Nanomed"},{"issue":"3","key":"3425_CR56","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0021-9258(17)49941-8","volume":"295","author":"NE Powers","year":"2020","unstructured":"Powers NE, Swartzwelter B, Marchetti C, de Graaf DM, Lerchner A, Schlapschy M, Datar R, Binder U, Edwards CK 3, Skerra A, Dinarello CA. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis. J Biol Chem. 2020;295(3):868\u201382.","journal-title":"J Biol Chem"},{"issue":"7","key":"3425_CR57","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/jor.22334","volume":"31","author":"AL McNulty","year":"2013","unstructured":"McNulty AL, Rothfusz NE, Leddy HA, Guilak F. Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation. J Orthop Res. 2013;31(7):1039\u201345.","journal-title":"J Orthop Res"},{"issue":"21","key":"3425_CR58","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.3390\/jcm10215027","volume":"10","author":"RT Meehan","year":"2021","unstructured":"Meehan RT, Regan EA, Hoffman ED, Wolf ML, Gill MT, Crooks JL, Parmar PJ, Scheuring RA, Hill JC, Pacheco KA, Knight V. Synovial fluid cytokines, chemokines and MMP levels in osteoarthritis patients with knee pain display a profile similar to many rheumatoid arthritis patients. J Clin Med. 2021;10(21):5027.","journal-title":"J Clin Med"},{"issue":"1","key":"3425_CR59","first-page":"82","volume":"13","author":"C Almeida-Santiago","year":"2022","unstructured":"Almeida-Santiago C, Quevedo-Abeledo JC, Hernandez-Hernandez MV, de Vera-Gonzalez A, Gonzalez-Delgado A, Gonzalez-Gay MA, Ferraz-Amaro I. Disease activity is more Associated with IL-1 Than with IL-6 in patients with rheumatoid arthritis. Life (Basel). 2022;13(1):82.","journal-title":"Life (Basel)"},{"issue":"1","key":"3425_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13075-019-2003-y","volume":"21","author":"S Mehta","year":"2019","unstructured":"Mehta S, Akhtar S, Porter RM, Onnerfjord P, Bajpayee AG. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture. Arthritis Res Ther. 2019;21(1):238.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3425_CR61","doi-asserted-by":"publisher","first-page":"11546","DOI":"10.1096\/fj.202000889R","volume":"34","author":"AK Ross","year":"2020","unstructured":"Ross AK, Coutinho de Almeida R, Ramos YFM, Li J, Meulenbelt I, Guilak F. The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines. FASEB J. 2020;34(9):11546\u201361.","journal-title":"FASEB J"},{"key":"3425_CR62","doi-asserted-by":"publisher","first-page":"715894","DOI":"10.3389\/fimmu.2021.715894","volume":"12","author":"S Kemble","year":"2021","unstructured":"Kemble S, Croft AP. Critical role of synovial tissue-resident macrophage and fibroblast subsets in the persistence of joint inflammation. Front Immunol. 2021;12:715894.","journal-title":"Front Immunol."},{"issue":"6","key":"3425_CR63","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/ard.2004.033662","volume":"65","author":"AA den Broeder","year":"2006","unstructured":"den Broeder AA, de Jong E, Franssen MJ, Jeurissen ME, Flendrie M, van den Hoogen FH. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice. Ann Rheum Dis. 2006;65(6):760\u20132.","journal-title":"Ann Rheum Dis"},{"key":"3425_CR64","doi-asserted-by":"publisher","first-page":"1759720X2211002","DOI":"10.1177\/1759720X221100294","volume":"14","author":"YJ Li","year":"2022","unstructured":"Li YJ, Chen Z. Cell-based therapies for rheumatoid arthritis: opportunities and challenges. Ther Adv Musculoskelet Dis. 2022;14:1759720X221100294.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3425_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.actbio.2021.03.062","volume":"133","author":"M Klimak","year":"2021","unstructured":"Klimak M, Nims RJ, Pferdehirt L, Collins KH, Harasymowicz NS, Oswald SJ, Setton LA, Guilak F. Immunoengineering the next generation of arthritis therapies. Acta Biomater. 2021;133:74\u201386.","journal-title":"Acta Biomater"},{"key":"3425_CR66","doi-asserted-by":"publisher","first-page":"1242126","DOI":"10.3389\/fbioe.2023.1242126","volume":"11","author":"G Lin","year":"2023","unstructured":"Lin G, Wang J, Yang YG, Zhang Y, Sun T. Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance. Front Bioeng Biotechnol. 2023;11:1242126.","journal-title":"Front Bioeng Biotechnol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-024-03425-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-024-03425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:04:36Z","timestamp":1730851476000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-024-03425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3425"],"URL":"https:\/\/doi.org\/10.1186\/s13075-024-03425-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4385938\/v1","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study followed international, national, and\/or institutional guidelines for humane animal treatment and complied with relevant legislation from Washington University in St Louis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FG is an employee and shareholder in Cytex Therapeutics, Inc. The other authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}